NETZSCH Trockenmahltechnik GmbH

AMT Receives € 1.1 Million Funding for Acute Intermittent Porphyria Gene Therapy as part of EU Consortium Grant

Go to page

Cytheris Announces Notice of Allowance for U.S. Patent Covering its IL-7

Go to page

Scientists sequence genome of the woodland strawberry, a model system for rosaceae plants - Research could provide model for other plants in the Rosaceae family, including almond, apple and peach

Go to page

SimPath licenses novel ORNL system for enhanced synthetic biology

Go to page

Targeted drug delivery without the normal side effects - Indo-Irish Biotech Startup Secures Funding to Accelerate Cancer and Rare Genetic Disease Therapy

Go to page

Prosensa wins “Emerging Star Award” at the European Mediscience Awards

Go to page

New Brain Protein - Surprising Discovery: Brain Variants of Protein Associated with Huntington's and Other Neurodegenerative Diseases Identified

Go to page

Gene evolution process discovered

Go to page

Dyax Corp. and Cubist Pharmaceuticals, Inc. Sign Development and Commercialization Agreement for DX-88 Surgical Indications

Go to page

Generex Biotechnology receives regulatory approval to initiate Phase III clinical trial for Generex Oral-lyn - Ministry of Health of the Ukraine approves Phase III protocol GEN084-OL for a number of clinical sites in the Ukraine

Go to page

Action Pharma focuses its strategy and appoints a new CEO

Go to page

Dyax Announces CEO Transition Plan - Gustav A. Christensen to Succeed Henry E. Blair as President and CEO on January 1, 2009

Go to page